Touraj Shokati

Touraj Shokati is an accomplished professional with extensive experience in the field of clinical laboratory affairs and research. Currently serving as the Vice President of Clinical Laboratory Affairs at HepQuant, LLC, Touraj has previously held significant roles including Director of Drug Metabolism and Pharmacokinetics at IC42 Clinical Research & Development, Group Leader of R&D at Roche Diagnostics GmbH, and Laboratory Director at TEQ Analytical Laboratories. Additionally, Touraj has worked as a Senior Research Scientist at the University of Colorado Denver. Academic qualifications include a Doctor of Philosophy (Ph.D.) in Analytical Chemistry/Biochemistry and a Master of Science (MS) in Analytical Chemistry, both obtained from the University of Bremen.